Breast cancer imaging with PET based radiopharmaceuticals other than 18F-FDG
R Vatsa, SS Singh, AG Ashwathanarayana… - Clinical Nuclear …, 2020 - journals.lww.com
Breast cancer is the most common cancer in women with rising incidence worldwide. 18 F-
FDG PET/CT imaging has already established itself as a pivotal modality for staging …
FDG PET/CT imaging has already established itself as a pivotal modality for staging …
Die Darstellungseigenschaften maligner und benigner hepatischer und pulmonaler Läsionen in der 68Ga-PSMA-PET/CT bei Patienten mit Prostatakarzinom
J Damjanovic - 2024 - refubium.fu-berlin.de
Hintergrund: Das Ziel der dieser Dissertation zugrunde liegenden Studien war es, die
Darstellungseigenschaften von Leber-und Lungenmetastasen sowie pulmonalen …
Darstellungseigenschaften von Leber-und Lungenmetastasen sowie pulmonalen …
Biopsy-proven diffuse mediastinal prostate cancer metastases negative on 18F-fluorocholine, diagnosed on 68Ga-PSMA and 18F-PSMA PET/CT
G Chaussé, T Niazi, GS Abikhzer… - Clinical nuclear …, 2017 - journals.lww.com
A 72-year-old man with prostate cancer (stage T3b, Gleason score 7) treated by radical
prostatectomy was found to have biochemical failure (prostate-specific antigen 8.5 ng/mL) …
prostatectomy was found to have biochemical failure (prostate-specific antigen 8.5 ng/mL) …
前列腺特异性膜抗原PET/CT 特异性分子显像在非前列腺癌诊断中的应用
刘特立， 刘辰， 张羽琪， 邓虞娇， 朱华， 杨志 - 肿瘤防治研究, 2019 - zlfzyj.com
前列腺特异性膜抗原(PSMA) 是由前列腺上皮细胞分泌的一种Ⅱ 型谷氨酸缩肽酶,
特异性高表达于前列腺癌及其转移灶的细胞中, 在多数实体瘤部位毛细血管内皮细胞中有较高 …
特异性高表达于前列腺癌及其转移灶的细胞中, 在多数实体瘤部位毛细血管内皮细胞中有较高 …
Prostate-specific membrane antigen in low-grade fibromatosis
RA Aghdam, M Hakiminejad… - Clinical Nuclear …, 2017 - journals.lww.com
We report a case of fibromatosis demonstrating prostate-specific membrane antigen (PSMA)–
positive scan. A 76-year-old man was under assessment because of rising prostate-specific …
positive scan. A 76-year-old man was under assessment because of rising prostate-specific …
[PDF][PDF] Development of Methods for the Radiolabeling of Hepatitis E Virus Nanoparticles and Their Biological Evaluation Aiming at Theranostic Applications
EE LAMBIDIS - 2022 - helda.helsinki.fi
Despite continuous advances in medicine, there is still a need for better diagnostics and
therapeutics against various diseases including cancer. When a single system combines the …
therapeutics against various diseases including cancer. When a single system combines the …
Development and Evaluation of a Chelator for Gallium-67/68
L Burgess - 2023 - ses.library.usyd.edu.au
The novel chelator, NOTET, a tetrazole analogue of NOTA, was successfully synthesised via
the tris-alkylation of TACN with chloroacetonitrile followed by [3+ 2] cycloaddition using …
the tris-alkylation of TACN with chloroacetonitrile followed by [3+ 2] cycloaddition using …
About the specificity of radiotracers for prostate cancer
M Soussan - European Journal of Nuclear Medicine and Molecular …, 2017 - Springer
Sir, I read with interest the paper by Schwenck et al.[1] describing the comparison of 68Ga-
PSMA-11 and 11C-choline for the detection of prostate cancer metastases. There is great …
PSMA-11 and 11C-choline for the detection of prostate cancer metastases. There is great …
PET Gallium-68 Imaging (68Ga) Using RM2
H Duan, A Iagaru - Prostate Cancer, An Issue of PET Clinics, E …, 2022 - books.google.com
One in every six to eight men will be diagnosed with prostate cancer (PC) during their
lifetime. 1 PC is the second most frequent non-cutaneous cancer in men with an estimated …
lifetime. 1 PC is the second most frequent non-cutaneous cancer in men with an estimated …
Prostate Specific Membrane Antigen Based Imaging
M Tuncel - Anatomy for Urologic Surgeons in the Digital Era …, 2021 - Springer
Positron emission tomography-computed tomography (PET-CT) performed with new
radiopharmaceuticals has revolutionized the imaging area in prostate cancer (Pca). 68 …
radiopharmaceuticals has revolutionized the imaging area in prostate cancer (Pca). 68 …